VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2020 | Allogeneic hemopoietic stem cell transplants for advanced phase CML

Elena Morozova, MD, PhD, RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation, discusses the clinical need and challenges of performing allogeneic hemopoietic stem cell transplants (allo-HSCT) in patients with advanced phase chronic myeloid leukemia (CML). Dr Morozova goes on to highlight the findings of a comparative study in which patients that received allo-HSCT had significantly improved four-year overall survival (OS) as compared to the non-transplanted group. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter